Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Feb 20, 2025

BUY
$309.38 - $337.38 $253,072 - $275,976
818 New
818 $264 Million
Q1 2022

Feb 20, 2025

SELL
$219.27 - $242.57 $553,218 - $612,004
-2,523 Closed
0 $0
Q4 2021

Feb 20, 2025

BUY
$198.88 - $227.6 $501,774 - $574,234
2,523 New
2,523 $568 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Clare Market Investments LLC Portfolio

Follow Clare Market Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clare Market Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clare Market Investments LLC with notifications on news.